Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of Sphingolipid Metabolism Enhances Resveratrol Chemotherapy in Human Gastric Cancer Cells

  • Shin, Kyong-Oh (College of Pharmacy and MRC, Chungbuk National University) ;
  • Park, Nam-Young (College of Pharmacy and MRC, Chungbuk National University) ;
  • Seo, Cho-Hee (College of Pharmacy and MRC, Chungbuk National University) ;
  • Hong, Seon-Pyo (Department of Oriental harmaceutical Sciences, College of Pharmacy, Kyung Hee University) ;
  • Oh, Ki-Wan (College of Pharmacy and MRC, Chungbuk National University) ;
  • Hong, Jin-Tae (College of Pharmacy and MRC, Chungbuk National University) ;
  • Han, Sang-Kil (College of Pharmacy and MRC, Chungbuk National University) ;
  • Lee, Yong-Moon (College of Pharmacy and MRC, Chungbuk National University)
  • Received : 2012.08.01
  • Accepted : 2012.09.03
  • Published : 2012.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Resveratrol, a chemopreventive agent, is rapidly metabolized in the intestine and liver via glucuronidation. Thus, the pharmacokinetics of resveratrol limits its efficacy. To improve efficacy, the activity of resveratrol was investigated in the context of sphingolipid metabolism in human gastric cancer cells. Diverse sphingolipid metabolites, including dihydroceramides (DHCer), were tested for their ability to induce resveratrol cytotoxicity. Exposure to resveratrol ($100{\mu}M$) for 24 hr induced cell death and cell cycle arrest in gastric cancer cells. Exposure to the combination of resveratrol and dimethylsphingosine (DMS) increased cytotoxicity, demonstrating that sphingolipid metabolites intensify resveratrol activity. Specifically, DHCer accumulated in a resveratrol concentration-dependent manner in SNU-1 and HT-29 cells, but not in SNU-668 cells. LC-MS/MS analysis showed that specific DHCer species containing C24:0, C16:0, C24:1, and C22:0 fatty acids chain were increased by up to 30-fold by resveratrol, indicating that resveratrol may partially inhibit DHCer desaturase. Indeed, resveratrol mildly inhibited DHCer desaturase activity compared to the specific inhibitor GT-11 or to retinamide (4-HPR); however, in SNU-1 cells resveratrol alone exhibited a typical cell cycle arrest pattern, which GT-11 did not alter, indicating that inhibition of DHCer desaturase is not essential to the cytotoxicity induced by the combination of resveratrol and sphingolipid metabolites. Resveratrol-induced p53 expression strongly correlated with the enhancement of cytotoxicity observed upon combination of resveratrol with DMS or 4-HPR. Taken together, these results show that DHCer accumulation is a novel lipid biomarker of resveratrol-induced cytotoxicity in human gastric cancer cells.

Keywords

References

  1. Apraiz, A., Idkowiak-Baldys, J., Nieto-Rementeria, N., Boyano, M. D., Hannun, Y. A. and Asumendi, A. (2012) Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death. Biochem. Cell Biol. 90, 209-223. https://doi.org/10.1139/o2012-001
  2. Aziz, M. H., Reagan-Shaw, S., Wu, J., Longley, B. J. and Ahmad, N. (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J. 19, 1193-1195. https://doi.org/10.1096/fj.04-3582fje
  3. Dudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A. and Das, D. K. (2008) Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol. J. Agric. Food Chem. 56, 9362-9373. https://doi.org/10.1021/jf801791d
  4. Edsall, L. C., Van Brocklyn, J. R., Cuvillier, O., Kleuser, B. and Spiegel, S. (1998) N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 37, 12892-12898. https://doi.org/10.1021/bi980744d
  5. Fukui, M., Yamabe, N. and Zhu, B. T. (2010) Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur. J. Cancer 46, 1882-1891. https://doi.org/10.1016/j.ejca.2010.02.004
  6. Gorelik, S., Ligumsky, M., Kohen, R., and Kanner, J. (2008) A novel function of red wine polyphenols in humans: prevention of absorption of cytotoxic lipid peroxidation products. FASEB J. 22, 41-46. https://doi.org/10.1096/fj.07-9041com
  7. Hsieh, T. C., Juan, G., Darzynkiewicz, Z. and Wu, J. M. (1999) Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59, 2596-2601.
  8. Idkowiak-Baldys, J., Apraiz, A., Li, L., Rahmaniyan, M., Clarke, C. J., Kraveka, J. M., Asumendi, A. and Hannun, Y. A. (2010) Dihydroceramide desaturase activity is modulated by oxidative stress. Biochem. J. 427, 265-274. https://doi.org/10.1042/BJ20091589
  9. Maier-Salamon, A., Bohmdorfer, M., Thalhammer, T., Szekeres, T. and Jaeger, W. (2011) Hepatic glucuronidation of resveratrol: interspecies comparison of enzyme kinetic profiles in human, mouse, rat, and dog. Drug Metab. Pharmacokinet. 26, 364-373. https://doi.org/10.2133/dmpk.DMPK-11-RG-006
  10. Miyaji, M., Jin, Z. X., Yamaoka, S., Amakawa, R., Fukuhara, S., Sato, S. B., Kobayashi, T., Domae, N., Mimori, T., Bloom, E. T., Okazaki, T. and Umehara, H. (2005) Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J. Exp. Med. 202, 249-259. https://doi.org/10.1084/jem.20041685
  11. Narayanan, B. A., Narayanan, N. K., Re, G. G. and Nixon, D. W. (2003) Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int. J. Cancer 104, 204-212. https://doi.org/10.1002/ijc.10932
  12. Nutakul, W., Sobers, H. S., Qiu, P., Dong, P., Decker, E. A., McClements, D. J. and Xiao, H. (2011) Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparison. J. Agric. Food Chem. 59, 10964-10970. https://doi.org/10.1021/jf202846b
  13. Santandreu, F. M., Valle, A., Oliver, J. and Roca, P. (2011) Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell Physiol. Biochem. 28, 219-228. https://doi.org/10.1159/000331733
  14. Santoro, R. and Blandino, G. (2010) p53: The pivot between cell cycle arrest and senescence. Cell Cycle 9, 4262-4263.
  15. Scarlatti, F., Sala, G., Somenzi, G., Signorelli, P., Sacchi, N. and Ghidoni, R. (2003) Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J. 17, 2339-2341. https://doi.org/10.1096/fj.03-0292fje
  16. Schulze, H., Michel, C. and van Echten-Deckert, G. (2000) Dihydroceramide desaturase. Methods Enzymol. 311, 22-30. https://doi.org/10.1016/S0076-6879(00)11063-8
  17. She, Q. B., Bode, A. M., Ma, W. Y., Chen, N. Y., Dong, Z. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604-1610.
  18. Signorelli, P., Munoz-Olaya, J. M., Gagliostro, V., Casas, J., Ghidoni, R. and Fabriàs, G. (2009) Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett. 282, 238-243. https://doi.org/10.1016/j.canlet.2009.03.020
  19. Spassieva, S. D., Rahmaniyan, M., Bielawski, J., Clarke, C. J., Kraveka, J. M. and Obeid, L. M. (2012) Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells. J. Lipid. Res. 53, 918-928. https://doi.org/10.1194/jlr.M019075
  20. Triola, G., Fabrias, G., Dragusin, M., Niederhausen, L., Broere, R., Llebaria, A. and van Echten-Deckert, G. (2004) Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanami de (GT11) in primary cultured cerebellar neurons. Mol. Pharmacol. 66, 1671-1678. https://doi.org/10.1124/mol.104.003681
  21. Ulrich, S., Huwiler, A., Loitsch, S., Schmidt, H. and Stein, J. M. (2007) De novo ceramide biosynthesis is associated with resveratrol-induced inhibition of ornithine decarboxylase activity. Biochem. Pharmacol. 74, 281-289. https://doi.org/10.1016/j.bcp.2007.04.001
  22. Yatomi, Y., Ruan, F., Megidish, T., Toyokuni, T., Hakomori, S. and Igarashi, Y. (1996) N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 35, 626-633. https://doi.org/10.1021/bi9515533

Cited by

  1. PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor Types vol.230, pp.5, 2015, https://doi.org/10.1002/jcp.24843
  2. Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease vol.88, pp.12, 2014, https://doi.org/10.1007/s00204-014-1386-4
  3. Δ10(E)-Sphingolipid Desaturase Involved in Fusaruside Mycosynthesis and Stress Adaptation in Fusarium graminearum vol.5, pp.1, 2015, https://doi.org/10.1038/srep10486
  4. Vitamin C Stimulates Epidermal Ceramide Production by Regulating Its Metabolic Enzymes vol.23, pp.6, 2015, https://doi.org/10.4062/biomolther.2015.044
  5. Resveratrol-induced transcriptional up-regulation of ASMase (SMPD1) of human leukemia and cancer cells vol.470, pp.4, 2016, https://doi.org/10.1016/j.bbrc.2016.01.134
  6. Resveratrol as an anti-cancer agent: A review 2018, https://doi.org/10.1080/10408398.2016.1263597
  7. Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology vol.197, 2016, https://doi.org/10.1016/j.chemphyslip.2015.07.025
  8. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms vol.1861, pp.2, 2017, https://doi.org/10.1016/j.bbagen.2016.11.033
  9. Resveratrol: A potential challenger against gastric cancer vol.21, pp.37, 2015, https://doi.org/10.3748/wjg.v21.i37.10636
  10. Cancer Prevention and Therapy with Polyphenols: Sphingolipid-Mediated Mechanisms vol.10, pp.7, 2018, https://doi.org/10.3390/nu10070940
  11. Resveratrol Action on Lipid Metabolism in Cancer vol.20, pp.11, 2012, https://doi.org/10.3390/ijms20112704
  12. Stearoyl-CoA Desaturase-1 Enzyme Inhibition by Grape Skin Extracts Affects Membrane Fluidity in Human Colon Cancer Cell Lines vol.12, pp.3, 2012, https://doi.org/10.3390/nu12030693